Send this to a friend

Biostage names three new directors, cuts net loss

Holliston biotech startup Biostage has added three new members to its board of directors simultaneous to its third-quarter earnings report showing a slower cash burn rate as the company gears up for U.S. Food & Drug Administration submissions.
All three come from the finance side of the industry, including Ting Li, a 20-year investment banking veteran currently a managing partner at China-based Donghai Securities CO., Ltd. Li’s appointmen ...

Fields marked in red are required
Your name
Your email
Recipient addresses
(Separate multiple addresses with commas)

Personal message

Copyright 2017 New England Business Media